Piramal Pharma Limited (BOM:543635)
India
· Delayed Price · Currency is INR 214.90
+2.95 (1.39%)
At close: May 13, 2025
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 290.39 billion as of May 14, 2025. Its market cap has increased by 58.20% in one year.
Market Cap
290.39B
Enterprise Value
334.17B
Revenue
89.49B
Ranking
n/a
PE Ratio
746.51
Stock Price
214.90
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 290.39B, an increase of 28.08%. That is a compound annual growth rate of 10.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 290.39B | -17.73% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 18.25T |
| HDFC Bank | 14.98T |
| Tata Consultancy Services | 13.10T |
| Bharti Airtel | 11.22T |
| ICICI Bank | 10.33T |
| State Bank of India | 7,154.42B |
| Infosys | 6,742.26B |
| Hindustan Unilever | 5,597.90B |